$CLPBY · Coloplast A/S Congress Trades

Rep. Josh Gottheimer (NJ-05) executed 21 trades in May 2025 across a diversified portfolio of technology, healthcare, and industrial stocks managed through Morgan Stanley Select UMA. Purchases included ABBV, APP, ASML, GLW, LLY, MSFT, CRM, SE, TEL, TSLA (4 separate purchases), and UBER, while sales included partial positions in GOOG, CLPBY, LLY, FI, GILD, UNICY, UPS, and ZTO. All transactions ranged from $1,001 to $15,000.

Rep. Josh Gottheimer (NJ-05) executed extensive trading activity in January 2025 through a Morgan Stanley managed account, with over 100 transactions involving purchases and sales across a diversified portfolio of blue-chip stocks, technology companies, and international equities. Most transactions ranged from $1,001-$15,000, with one notable sale of Merck & Company (MRK) in the $15,001-$50,000 range on January 27, 2025.

Rep. Josh Gottheimer (NJ-05) executed a diverse portfolio of transactions in December 2024, including significant options activity on Microsoft (MSFT) with multiple call option sales and purchases ranging from $1,000,001-$5,000,000, along with numerous stock purchases and sales across major companies including Apple, Goldman Sachs, Johnson & Johnson, Walmart, and Tesla, with most individual stock transactions in the $1,001-$15,000 range.

Rep. Josh Gottheimer (NJ-05) conducted extensive trading activity in May 2024, including 27 stock transactions ranging from $1,001-$15,000 each and four significant Microsoft call option positions totaling $1,000,001-$5,000,000. Notable purchases included GOOG, BKNG, CLPBY, LOPE, HLN, INTA, KKR, NTDOY, SWTX, SSMXY, TSLA, BWIN, and UMBF, while sales included ALG, ALGN, AMSF, BX, EXAS, INSM, LOW, MELI, META, MNST, RPD, CRM, TXRH, and UBER.